- Raw materials
- Other substances
- Hydrolyzed soy protein
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Hydrolyzed soy protein API Manufacturers & Suppliers
1 verified results
All Hydrolyzed soy protein data. Full access. Full negotiation power
Commercial-scale Suppliers
Employees: 20
All certificates
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Hydrolyzed soy protein | CAS No: 68607-88-5 | GMP-certified suppliers
A medication that serves as an investigational ingredient primarily utilized in research for nutritional and bioactive peptide applications within pharmaceutical and nutraceutical development.
Product Snapshot
- Hydrolyzed soy protein is provided as a topical gel formulation
- It is primarily investigated for dermatological applications
- This product is currently experimental and not approved in the US market
Clinical Overview
The pharmacological properties and mechanism of action of hydrolyzed soy protein have not been clearly defined in the literature. As a mixture of peptides and amino acids resulting from the hydrolysis of soy protein, it may influence biological systems through nutritional or bioactive peptide pathways; however, no specific pharmacodynamics data are available at this time.
Absorption, distribution, metabolism, and excretion (ADME) parameters for hydrolyzed soy protein have not been characterized in the context of therapeutic drug development. Given its peptide nature, oral bioavailability and systemic exposure would differ significantly from small molecule drugs and typically involve digestion and metabolic pathways common to dietary proteins.
Safety and toxicity considerations for hydrolyzed soy protein depend largely on the intended use and exposure levels. Potential allergenicity is a notable concern due to its derivation from soy, a known allergen. Toxicological data are limited, and no standardized safety profile has been established for clinical use or pharmaceutical applications.
Currently, hydrolyzed soy protein is not associated with any approved pharmaceutical brands or specific therapeutic usage. Its role remains primarily within experimental settings including nutraceutical research, food science, and preliminary pharmaceutical excipient development.
For sourcing and quality control, strict adherence to specifications for protein purity, degree of hydrolysis, microbial limits, and allergen content is critical. Procurement should prioritize suppliers compliant with Good Manufacturing Practice (GMP) and regulatory standards relevant to pharmaceutical-grade materials to ensure consistency, safety, and traceability of the active pharmaceutical ingredient.
Identification & chemistry
| Generic name | Hydrolyzed soy protein |
|---|---|
| Molecule type | Biotech |
| CAS | 68607-88-5 |
| UNII | 1394NXB9L6 |
| DrugBank ID | DB15607 |
Formulation & handling
- Hydrolyzed soy protein is a biotech-derived topical gel, requiring formulation stability considerations for protein integrity.
- Due to its peptide nature, excipients should be selected to minimize degradation and maintain bioactivity.
- Handling should ensure protection from microbial contamination given its experimental topical application.
Regulatory status
| Lifecycle | The active pharmaceutical ingredient (API) has patent protection in the US set to expire within the next 12 months, indicating an approaching transition from exclusivity to increased generic competition. As a result, the US market is expected to experience greater product availability and pricing adjustments associated with market maturity. |
|---|
| Markets | US |
|---|
Supply Chain
| Supply chain summary | The manufacturing landscape for Hydrolyzed soy protein involves multiple originator companies supplying the US market. Branded products such as P3 Ai have a notable presence, primarily within the United States. There is no specific patent expiry information provided, indicating limited visibility on the timing or extent of generic competition. |
|---|
Hydrolyzed soy protein is a type of Other substances
The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.
Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.
Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.
Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.
In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.
Hydrolyzed soy protein API manufacturers & distributors
Compare qualified Hydrolyzed soy protein API suppliers worldwide. We currently have 1 companies offering Hydrolyzed soy protein API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Blue Eyes Biotech Co., Lt... | Producer | United Kingdom | United Kingdom | CoA | 35 products |
When sending a request, specify which Hydrolyzed soy protein API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Hydrolyzed soy protein API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
